A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

检 索： 期刊全称 刊名关键词 ISSN         高级检索

期刊名称：LANCET PSYCHIATRY ISSN： 2215-0374 出版频率： Monthly 出版社： ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB   出版社网址： http://www.journals.elsevier.com/the-lancet-psychiatry/ 期刊网址： http://www.thelancet.com/journals/lanpsy/issue/current 影响因子： 26.481 (2020年) 18.329(2018年) 15.233(2017年) 11.588(2016年) 5.756(2015年) Not Available(2014年) 主题范畴： PSYCHIATRY 变更情况： Newly Added by 2015 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal The Lancet Psychiatry launched in print and online in June 2014, following in the footsteps of other Lancet specialty journals such as The Lancet Oncology and The Lancet Neurology. The journal offers the same fast track experience offered by its sister journals for all authors of research papers that are selected for peer review, where articles can be published online within 8 weeks of submission. The journal publishes a range of article types in psychiatry, including Original Research, Reviews, Personal Views, Comments, and News articles. Topics include psychopharmacology, psychotherapy and psychosocial approaches to all psychiatric disorders, across the life course. The journal covers innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of thinking about mental illness promoted by social psychiatry. The journal will also advocate strongly for the rights of people with mental health disorders, and welcome the voices of service users. Visit www.thelancet.com/psychiatry for more information. Instructions to Authors The Lancet Psychiatry: Information for Authors The Lancet Psychiatry considers any original research contribution that advocates change in or illuminates clinical practice and informative reviews on any topic connected with Psychiatry. Because the journal has an international readership. It is vital that articles should be written clearly and should not assume a level of knowledge above that of, say, a reasonably well-read general psychiatrist. One way to find out if your article is understandable to those reading outside their immediate field of interest is to show the manuscript to colleagues in other sub-specialties. If they find it difficult to follow, so will a good proportion of the readership. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. Further details on the different sections of The Lancet Psychiatry, and how to submit to the journal, are provided below. If you require further clarification, the journal’s editorial staff will be pleased to help (email psychiatry@lancet.com). Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines. How to submit your paper Statements, permissions, and signatures Authors and contributors Conflicts of interest Role of the funding source Role of medical writer or editor Patients' consent and permission to publish Signatures Types of article and manuscript requirements Formatting guidelines Guidelines for supplementary material Disclosure of results before publication Fast-track publication Online First publication How The Lancet Psychiatry handles your paper Open access and funding What happens after publication? Download a PDF version of the full guidelines for authors of The Lancet Psychiatry. LAST UPDATE: February, 2016 Editorial Board Editor Niall Boyce Deputy Editor Joan Marsh Senior Editor Catherine Quarini Editorial Advisory Board The Lancet Psychiatry is pleased that the people listed below have agreed to serve on the Editorial Advisory Board. They reflect the values of our journal: a global community of experts committed to excellence in research and strong advocacy for the rights of people with mental health problems. Mohammed T Abou-Saleh Mohammed T Abou-Saleh is Professor of Psychiatry, St George’s, University of London. He has previously held positions as Chief Executive Officer of Naufar, Qatar Addiction Treatment and Rehabilitation Centre (2011-2013); Director of Research and Development (2002-2008) and Clinical Director of Addiction Services ( 1998-2004) for South West London and St George's Mental Health Trust; Chairman of the World Psychiatric Association Section on Biological Psychiatry (1998-present); Consultant for the World Health Organization; Vice-President for the Constituency Development of the World Federation for Mental Health (2011-2015); Professor and Chairman of the Department of Psychiatry and Associate Dean for Clinical Affairs, United Arab Emirates University (1991-1998), as well as Secretary General of the Arab Federation of Psychiatrists (1994-1997) and Chairman of the Middle East Group of the Royal College of Psychiatrists, UK (1997-1998). Louis Appleby Louis Appleby is Professor of Psychiatry at the University of Manchester where he leads the Centre on Mental Health and Risk, investigating suicide, homicide and the risks from parental mental illness. He is Director of the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness, a UK-wide study that aims to improve the safety of mental health care. From 2000-2010 he was National Director for Mental Health in England, playing a central role in reforming community care. From 2010-2014 he was National Clinical Director for Health and Justice, leading the development of diversion services for offenders with mental health problems. He currently leads the National Suicide Prevention Strategy and is a member of the Board of the Care Quality Commission. He was awarded a CBE for services to medicine in 2006. Gisèle Apter Gisèle Apter is the director of Infant and Juvenile Psychiatry at Erasme Hospital, Paris, France and also directs a parent-infant psychiatric research laboratory affiliated with the University Paris Diderot. Gisèle studied general, child, and perinatal psychiatry and infant psychology at the University Pierre et Marie Curie in Paris, followed by training in developmental psychology at the Children’s Hospital Harvard Medical School in Boston, USA. Gisèle is President of the Société de l'Information Psychiatrique. Her research focuses on infants of parents with personality disorder and the transmission of disorganized attachment and on the impact of maternal mental health on the developing infant. She is involved in many international projects, such as the Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium. Ricardo Araya Ricardo Araya is Professor of Global Mental Health at the London School of Hygiene and Tropical Medicine, UK. He is a member of the scientific panel of the Global Health Trials scheme funded by Wellcome Trust, MRC, and DfID. He has more than 20 years of research experience working in low-and-middle income countries on projects to develop interventions to improve the mental health of underserved populations. As such he is involved in projects in Nigeria, Zimbabwe, Tanzania, Uganda, Chile, Brazil, Peru, Colombia, Guatemala, and the UK. He has more than 200 publications in peer-reviewed journals including several in The Lancet. Jean-Michel Azorin Jean-Michel Azorin, MD, is Professor of Psychiatry at the Mediterranean University School of Medicine and Chief, Psychiatry Service, Sainte-Marguerite Hospital in Marseille, France. Professor Azorin studied medicine and psychiatry at the University of Marseille Medical School, then trained in biological psychiatry at the University of Geneva. He studies affective symptoms in schizophrenia and was involved in the conception and implementation of rating scales to assess anxiety and depression in schizophrenia. Professor Azorin is an expert for the French National Drugs Agency and contributed to the French Consensus Treatment of Schizophrenia. He has conducted national and global collaborative studies on bipolar mania and depression, and led many studies of newer antipsychotics, particularly the French/Canadian Clozapine Risperidone Study. He has published more than 250 papers on schizophrenia and mood disorders, is the author of one book on vulnerability models in schizophrenia and the co-editor of one textbook on second-generation antipsychotics. Simon Baron-Cohen Simon Baron-Cohen is Professor of Developmental Psychopathology, Director of the Autism Research Centre, University of Cambridge, and Clinical Director of the CLASS Clinic in Cambridgeshire and Peterborough NHS Trust, UK. He is the author of several books (Mindblindness, The Essential Difference, Prenatal Testosterone in Mind, and Zero Degrees of Empathy), and the DVDs Mind Reading and The Transporters, which aim to help people with autism learn emotion recognition, both nominated for BAFTA awards. He has received numerous awards including the Kanner-Asperger Medal. He is a Fellow of the British Psychological Society, the British Academy, and the American Psychological Association. He is Vice-President of the National Autistic Society, was President, Psychology Section of the British Association, and Vice-President, International Society for Autism Research. He was Chair of the NICE Guidelines for Autism (Adults), and is Chair of the Psychology Section of the British Academy. Dinesh Bhugra Dinesh Bhugra, CBE, is Professor of Mental Health and Cultural Diversity at the Institute of Psychiatry, King’s College London. He is also an Honorary Consultant at the Maudsley Hospital. His research interests are in cultural psychiatry, sexual dysfunction and service development. He has authored/co-authored over 350 scientific papers, chapters and 30 books. He is the Editor of the International Journal of Social Psychiatry, International Review of Psychiatry and International Journal of Culture and Mental Health. From 2008 to 2011 Professor Bhugra was President of the Royal College of Psychiatrists. He is currently the Chair of the Mental Health Foundation and President-Elect of the World Psychiatric Association. Deborah L. Cabaniss Deborah L. Cabaniss, M.D. is Clinical Professor of Psychiatry at the Columbia University College of Physicians and Surgeons and Director of Psychotherapy Training in the Department of Psychiatry at Columbia. She is the winner of numerous teaching awards, and has published extensively about psychoanalytic and psychiatric education. Her books, Psychodynamic Psychotherapy: A Clinical Manual and Psychodynamic Formulation, are widely used texts in the USA and elsewhere. Dr. Cabaniss is also the director of the Virginia Apgar Academy of Medical Educators at the Columbia University College of Physicians and Surgeons. Andrea Cipriani Andrea Cipriani is an Associate Professor in the Department of Psychiatry, University of Oxford, and a consultant psychiatrist at Oxford Health NHS Foundation Trust, UK. He is also Lecturer in Psychiatry at the Department of Public Health and Community Medicine, University of Verona, Italy. His research work focuses on psychopharmacology and evidence-based medicine (systematic reviews and meta-analyses, clinical trials, network meta-analyses and individual patient data meta-analyses), with a specific interest in the development and evaluation of treatments for people with major depression and bipolar disorder. He has served on the advisory board for the National Institute for Health and Care Excellence and is Editor of the journal Evidence-Based Mental Health. Louisa Degenhardt Louisa Degenhardt is Professor of Epidemiology and NHMRC Principal Research Fellow at the National Drug and Alcohol Research Centre at the University of New South Wales, Sydney, Australia. She has honorary professorial appointments at University of Melbourne’s School of Population and Global Health, Murdoch Children’s Research Institute, and University of Washington’s Department of Global Health in the School of Public Health. Louisa conducts diverse epidemiological studies on drug dependence, particularly opioids. Her work informs policy on health, corrective services, and law enforcement responses. Louisa is a member of WHO’s Technical Advisory Group on Alcohol and Drug Epidemiology, is on the Core Analytic team for the ongoing Global Burden of Disease study led by the Institute for Health Metrics and Evaluation at the University of Washington, Seattle, USA, and led the Secretariat for the Reference Group to the UN on injecting drug use and HIV from 2007-2010. Annette Erlangsen Annette Erlangsen is Program Leader at the Research Unit of the Mental Health Centre Copenhagen, Denmark and holds an Adjunct Associate Professorship at the Department of Mental Health at Johns Hopkins Bloomberg School of Public Health, USA. Annette is dedicated to evidence-based research on prevention of suicide: she has conducted studies on psychosocial interventions for people at risk of suicide, bereaved by suicide, and affected by suicide attempt, as well as on suicide in high-risk populations and research applied to record linkage data. Annette has received the Alexander Gralnick Award of the American Association of Suicidology and the Danish Nordentoft Award. Michael Farrel Michael Farrell has been the Director of the National Drug and Alcohol Research Centre at the University of New South Wales, Sydney, Australia since March 2011. He did his original undergraduate training in Dublin, Ireland, then worked in London for over 20 years where he was a Consultant Addiction Psychiatrist in the Maudsley Hospital and a Professor of Addiction Psychiatry at the Institute of Psychiatry, Kings College London. He is still a visiting Professor at the Institute. His extensive research interests include treatment evaluation, drug dependence in prisons, Evidence Based Practice and Treatment Evaluation, translation of new evidence into practice, as well as broad based population studies based on the UK National Psychiatric Morbidity Programme. He is a founding Editor of the Cochrane Drug and Alcohol Group. He has published over 200 scientific papers, is a member of the WHO Expert Committee on Drug Dependence and has undertaken a wide range of work for international agencies and for National Governments on aspects of National Drug Policies. Seena Fazel Seena Fazel is Professor of Forensic Psychiatry at the University of Oxford, a Wellcome Trust Senior Research Fellow in Clinical Science, and a consultant forensic psychiatrist at Oxford Health NHS Foundation Trust, UK. His research work focuses on relationships between severe mental illness and violent crime, the mental health and suicide risk of prisoners, and violence risk assessment. He has served on advisory boards for NHS research funding committees and the crime reduction charity NACRO, and given evidence to the UK Government Justice Select Committee and the UN-backed Khmer Rouge war crimes tribunal. He is a Fellow of the Royal College of Psychiatrists, and works clinically in a local prison and at the interface of general and forensic psychiatry. John Geddes Professor Geddes is Honorary Consultant Psychiatrist at the Oxford Health NHS Foundation Trust where he provides clinical care for patients with mood disorders, specialising in bipolar disorder. He is also Director of R&D at the Oxford Health NHS Foundation Trust. His research focuses on the development and evaluation of treatments for people with bipolar and other mental disorders. He has established large cohorts of patients, developed new approaches to self management and monitoring, and conducted clinical trials as well as influential research syntheses. By involving patients in research, his team has been able to characterize the nature of mood disorder more accurately. His current research aims to use this knowledge to investigate the basic neurobiology and genetic mechanisms of the disorder. His research strategy increasingly combines the power of large scale epidemiological methods with the precision of neurobiological investigation. Professor Geddes is a Fellow of the Royal College of Psychiatrists and, in 2010 was named Academic Psychiatrist of the Year by the Royal College of Psychiatrists. In 2008, he was awarded an Honorary Fellowship of the American College of Psychiatrists Oye Gureje Oye Gureje is Professor of Psychiatry and Director, WHO Collaborating Centre for Research and Training in Mental Health, Neuroscience and Substance Abuse at the University of Ibadan, Nigeria. He serves on the WHO International Advisory Group for the Revision of ICD-10 Chapter on Mental and Behavioural Disorders, Chairs the WorkGroup on Somatic Distress and Dissociative Disorders and Co-Chairs the Field Studies Coordinating Group. He has been President of the African Association of Psychiatrists and Allied Professions (2009 – 2014). A recipient of the Nigerian National Order of Merit, the country’s highest honor for academic achievement, Professor Gureje Chairs the Mental Health Action Committee of the Federal Ministry of Health of Nigeria. Claudia Hammond Claudia Hammond is an award-winning broadcaster, writer and psychology lecturer. She is the presenter of All in the Mind & Mind Changers on BBC Radio 4 and Health Check on BBC World Service Radio and BBC World News TV. Claudia is on the part-time faculty at Boston University's London base, where she lectures in health and social psychology. She is the author of two psychology books, Emotional Rollercoaster: a journey through the science of feelings and Time Warped: Unlocking the mysteries of time Perception which in 2013 won the Popular Science Book award from the British Psychological Society and the first Aeon Transmission Prize. Claudia has also won the British Neuroscience Association Public Understanding of Neuroscience Award, The British Psychological Society's Media Public Engagement & Media Award and the Society for Personality and Social Psychology's Media Achievement Award in the US. Keith Hawton Keith Hawton is Professor of Psychiatry and Director of the Centre for Suicide Research at Oxford University Department of Psychiatry, UK. He is also a National Institute for Health Research Senior Investigator and Fellow of the Academy of Medical Sciences. For more than 35 years, he and his research group have been conducting investigations concerning the causes, treatment, prevention and outcome of suicidal behaviour. He has received the Stengel Research Award from the International Association for Suicide Prevention (1995), the Dublin Career Research Award from the American Association of Suicidology (2000), the Research Award of the American Foundation for Suicide Prevention (2002), and, in 2013, the Morselli Medal from the International Association of Suicide Research. Sonia Johnson Sonia Johnson is Professor of Social and Community Psychiatry at University College London, UK. Her interest in social aspects of mental health was encouraged by completing an MSc in Social Psychology at the London School of Economics after qualifying in Medicine at the University of Oxford. At UCL, she leads a research group that focuses on the development and evaluation of complex interventions for adults of working age with serious mental health problems. Current studies include developing and testing a fidelity measure for crisis resolution teams, randomised controlled trials of an intervention for reducing cannabis use in early psychosis and of a peer-led self management programme for people being discharged from crisis teams. Sonia’s clinical work is as a consultant psychiatrist in the Camden and Islington NHS Foundation Trust’s Early Intervention Service. Flavio Kapczinski Flavio Kapczinski is a full Professor at the Federal University in Porto Alegre, Brazil and an Invited Professor at the University of Paris II in France. In 2013, he was appointed a member of the Brazilian Academy of Sciences and won the Mogens Schou Award for research and education in psychiatry. His work has shed light on the biological underpinnings of the decline in cognition and physical health that takes place among patients with bipolar disorder. He has also contributed to the development and clinical use of the concept of staging in bipolar disorder. Kiyoto Kasai Kiyoto Kasai is a professor in the Department of Neuropsychiatry in the Graduate School of Medicine, University of Tokyo, Japan. He earned his M.D. in 1995 and his Ph.D. in Psychiatry in 2004, both from the University of Tokyo. He gained experience at the University of Tokyo Hospital and National Center of Neurology and Psychiatry, before an appointment as visiting instructor at Harvard Medical School, USA, from 2000 to 2002. He returned to the University of Tokyo Hospital Department of Neuropsychiatry in 2002 as instructor, and was appointed assistant professor in 2003 and professor and head of the Department of Neuropsychiatry in 2008. Professor Kasai’s research focuses on the early diagnosis of and support for schizophrenia patients, and recently on community mental health and preventive medicine. Professor Kasai is the recipient of multiple awards, including the Distinguished Investigator Award from the Japanese Society of Biological Psychiatry in 2002, and the Young Investigator Award from the Japan Neuroscience Society in 2008. Barbara Franke Barbara Franke is Professor of Molecular Psychiatry at the Radboud University in Nijmegen, The Netherlands, a Principal Investigator at the Donders Institute for Brain, Cognition and Behaviour in Nijmegen, and the chair of the Cognomics Initiative. As a molecular biologist and geneticist, her research is focused on understanding the genetic contribution to psychiatric disorders, in particular ADHD. In addition to gene-identification approaches, she uses bioinformatics, imaging genetics and small animal models to map the biological pathways leading from gene to disease. It is her goal to make genetic information useful for improving the diagnosis and treatment of psychiatric disorders. Siegfried Kasper Siegfried Kasper is Professor of Psychiatry and Chairman of the Department of Psychiatry and Psychotherapy at the Medical University of Vienna, Austria. Dr. Kasper has published extensively in various areas of psychiatry and served on the executive committees and advisory boards of national and international societies, such as the European College of Neuropsychopharmacology and the European Psychiatric Association. He has been elected to the Executive Committee of the International College of Neuropsychopharmacology (CINP) for 2012-2016. Dr. Kasper is Chair of the World Psychiatric Association (WPA) Section of Pharmacopsychiatry. He is President of the Austrian Society of Drug Safety in Psychiatry (ÖAMSP) and Past-President of the Austrian Society of Neuropsychopharmacology and Biological Psychiatry (ÖGPB). He is an Honorary Member of the Czech and Romanian Societies of Neuropsychopharmacology, the Hungarian Psychiatric Association and a Fellow of the Royal College of Psychiatrists, UK, as well as of the Ukrainian Association of Psychiatry, and an Honorary Professor at the University of Hong Kong. From 2005 to 2009 Dr. Kasper was President of the World Federation of Societies of Biological Psychiatry and was appointed Honorary President in 2013. Dr Kasper is Chief-Editor of the World Journal of Biological Psychiatry and the International Journal of Psychiatry in Clinical Practice, and Field Editor of the International Journal of Neuropsychopharmacology. David W. Kissane David W. Kissane is an academic psychiatrist, psycho-oncology researcher and author. He is currently the Head of Psychiatry for Monash University in Australia, recently the Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center in New York and previously the Foundation Chair of Palliative Medicine at the University of Melbourne. His academic interests include group, couples and family psychotherapy trials, communication skills training, studies of existential distress, and the ethics of end-of-life care. He is best known for his model of family therapy delivered to ‘at risk’ families during palliative care, which prevents complicated grief and depression in bereavement. Michael Krausz Michael Krausz is Professor of Psychiatry, Epidemiology and Public Health at the University of British Columbia in Vancouver, Canada. He started his professional carrier as a registered nurse in adolescent psychiatry, then studied Medicine in Hamburg, Germany until 1984, where he also did his residency and his academic degrees. He became a full Professor in 1994. In 2005 he was selected as UBC-PHC Leadership Chair for Addiction Research at the University of British Columbia. He is the Founding Editor of European Addiction Research, and has co-authored over 300 peer-reviewed publications especially addressing severe addiction and complex concurrent disorders. David J. Kupfer David J. Kupfer is Thomas Detre Professor of the Department of Psychiatry at the University of Pittsburgh School of Medicine, having joined the faculty at the University of Pittsburgh in 1973 as Associate Professor of Psychiatry and Director of Research and Research Training at Western Psychiatric Institute and Clinic, becoming Professor of Psychiatry in 1975. From 1983–2009, he served as Chair of the Department of Psychiatry at the University of Pittsburgh School of Medicine, and Director of Research at Western Psychiatric Institute and Clinic, facilitating the coordination and expansion of investigations among the department's 200 faculty. He promoted widespread collaborations between clinical investigators in psychiatry and those in the basic neurosciences. Dr. Kupfer has authored or co-authored more than 1,050 articles, books, and book chapters. His own research has focused primarily on long-term treatment strategies for recurrent mood disorders, the pathogenesis of depression, and the relationship between biomarkers and depression. Jun Soo Kwon Jun Soo Kwon is the Chair and Professor of the Department of Psychiatry, Seoul National University & Brain and Cognitive Sciences, Seoul National University, Korea. He is a Director of the 'Seoul Youth Clinic', an early detection and intervention programme for people with clinical and genetic high risk for psychosis in Korea (http://youthclinic.org). He studies brain structural/functional changes in schizophrenia and obsessive-compulsive disorder that occur with treatment, using various brain imaging tools (MRI/fMRI/EEG/PET). He is on the Board of Directors of the International Schizophrenia Research Society and the Council of the Asian College of Neuropsychopharmacology. He has published more than 300 papers including over 190 SCI papers in international journals. Stephen Lawrie Stephen Lawrie is a Professor of Psychiatry and Head of the Division of Psychiatry at the University of Edinburgh, UK, and an Honorary Consultant Psychiatrist at the Royal Edinburgh Hospital. He is a Fellow of the Royal College of Psychiatrists, the Royal College of Physicians (Edinburgh) and the European College of Neuropsychopharmacology. During 2014, he is a Beltane Fellow for Public Engagement in Science. Stephen is Director of the Scottish Mental Health Research Network and Director of the Medical Research Foundation- and Medical Research Council-funded UK Clinical Research Training Fellowship programme for Mental Health (PsySTAR). As a practising clinician and clinically oriented researcher, Stephen is interested in clinical applications of brain imaging in psychosis, with a view towards objective diagnostic aids in psychosis and psychiatry, and in the development of novel treatments that might enhance outcomes in patients with established psychoses and possibly even prevent the onset of psychosis in high risk populations. Stefan Leucht Prof. Dr. med. Stefan Leucht has been practising at the Department of Psychiatry and Psychotherapy of the Technische Universität München, Munich, Germany since 1994. In 2002/2003 he spent a year as a research associate at the Zucker Hillside Hospital, Albert Einstein College of Medicine, in New York. He was appointed Associate Professor in July 2011, and he has been Vice-Chairman of the department since 2009. In 2013/14 he was a visiting professor at the University Department of Psychiatry in Oxford and at the Institute of Psychiatry, King’s College London. He is an editor of the Cochrane Schizophrenia Group. Dr. Leucht's research focus is psychopharmacology and evidence-based medicine in schizophrenia with a focus on meta-analyses, clinical trials and the improvement of methodology of studies in this area. He also has a research interest in pharmacogenetics, compliance enhancement strategies and medical decision making. Patrick McGorry Patrick McGorry is Executive Director of Orygen Youth Health Research Centre and Professor of Youth Mental Health at the University of Melbourne, Australia. OYHRC comprises Australia’s largest youth mental health research centre and a linked clinical service targeting the needs of young people with emerging serious mental illness. Professor McGorry was the 2010 “Australian of the Year”. Together with the Orygen Centre, he has put Australia at the forefront of research, innovation and transformational reform in early intervention and youth mental health, creating prototypes, notably “EPPIC” and “headspace” on which many other youth mental health services around the world are increasingly based. Harry Minas Harry Minas is Director of the Centre for International Mental Health, Melbourne School of Population and Global Health, The University of Melbourne, Australia; Director of the Victorian Transcultural Mental Health Unit; and a member of the WHO Expert Advisory Panel on Mental Health. He is a psychiatrist whose main interests are in mental health system development, particularly in low-resource, disaster and conflict settings; culture and mental health, with a focus on mental health of immigrant and refugee communities and the development of services for culturally diverse societies; and the human rights of people with mental illness. He founded Australasian Psychiatry, which he edited for eight years, and in 2007 founded and is Editor-in-Chief of International Journal of Mental Health Systems. Charles Newton Charles Newton has spent most of his working life in Africa. He qualified from the University of Cape Town, South Africa, and did his post graduate training in Manchester and London, UK. He helped set up a research unit in Kilifi, Kenya in 1989, before going to Johns Hopkins for a 2-year post doctoral fellowship. He completed his training in Paediatric Neurology at Great Ormond Street Children’s Hospital in London. In 1998 he was awarded a Wellcome Trust Senior Clinical Fellowship to return to Kenya to study CNS infections in children and epilepsy at the Kenya Medical Research Institute in Kilifi. His research included the neurological deficits and neurocognitive impairment following falciparum malaria and he established the association with the development of epilepsy. Subsequently, he has studied epilepsy in five countries, to address the treatment gap and stigma. He is examining the neurocognitive sequelae of sickle cell disease, as well as the relationship between neonatal insults, CNS infections such as HIV and bacterial meningitis, and neurodevelopmental disorders including autism. In 2011 he was appointed to the Cheryl and Reece Scott Professorship of Psychiatry at the University of Oxford, where he concentrates on the epidemiology of neurodevelopmental disorders and mental illness, particularly in Africa. Unaiza Niaz Unaiza Niaz is The Director of The Psychiatric Clinic and Stress Research Center in Karachi, Pakistan. She is also Visiting Professor of the University of Health Sciences,Lahore and Visiting Faculty of Dow University of Health Sciences, Karachi. She studied in both the UK, where she is a Fellow of the Royal College of Psychiatry, and at Johns Hopkins in the USA. Dr Niaz is Founder and President of the Pakistan Society for Traumatic Stress Studies, Chair of the WPA Section on Woman’s Mental Health, an Advisory Council Board Member of the International Association of Women’s Mental Health and Vice President Eastern Mediterranean Region and Board Member of the World Federation for Mental Health. Dr Niaz has published about 80 scientific papers and authored nine books, including Wars, Insurgencies and Terrorist Attacks: A psychosocial Perspective from the Muslim World (Oxford University Press 2011) John O’Brien John O’Brien is Professor of Old Age Psychiatry in the Department of Psychiatry at the University of Cambridge, UK, having previously been Professor of Old Age Psychiatry at Newcastle University. He is also a UK National Institute for Health Research Senior Investigator. His research interests include the application of neuroimaging in old age psychiatry, dementia with Lewy bodies, the role of vascular factors in dementia and depression and clinical trials. He has been a member of the National Institute for Health and Clinical Excellence (NICE), the British Association of Psychopharmacology and the European Federation of Neurological Sciences Dementia Guideline groups. He is Past President of the International College for Geriatric Psychoneuropharmacology, the National Dementia Research lead for the Dementias and Neurodegenerative Diseases research network in England and Treasurer of the International Vas-Cog Society. Maria A Oquendo Maria A Oquendo is Professor and Vice-Chair in Psychiatry at Columbia University and New York State Psychiatric Institute. Her NIMH-funded research projects focus on suicidal behavior in affective disorders and her research training programmes on translational neuroscience and Global Mental Health. Her awards include Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill (1993, 2002), Simon Bolivar Award (2010), and American Foundation for Suicide Prevention Research Award (2013), Stengel Award for Suicide Prevention Research (2013). She was named Honorary Professor, Universidad Peruana Cayetano Heredia, Lima, Peru (2011). She has over 250 peer reviewed publications. Vikram Patel Vikram Patel is a Professor of International Mental Health and Wellcome Trust Senior Research Fellow in Clinical Science at the London School of Hygiene & Tropical Medicine, UK. He is the Joint Director of the School’s Centre for Global Mental Health and Honorary Director of the Public Health Foundation of India's Centre for Mental Health. He is a co-founder of Sangath, a community based NGO in India. He is a Fellow of the UK's Academy of Medical Sciences and serves on the WHO’s Expert Advisory Group for Mental Health and the Mental Health Policy Group of the Government of India. His book Where There Is No Psychiatrist has become a widely used manual for community mental health in developing countries. He is based in Goa and New Delhi, India. George Patton George Patton is the Professor of Adolescent Health Research based in the Centre for Adolescent Health at the University of Melbourne and Murdoch Childrens Research Institute. He is a Senior Principal Research Fellow with Australia’s National Health and Medical Research Council. A psychiatric epidemiologist with a clinical background in Child and Adolescent Psychiatry, he has published widely on global patterns of child and adolescent health, the epidemiology of common adolescent mental disorders, substance abuse and NCD risks arising in adolescents, sexual and reproductive health, and early psychosis. He is currently secretary-general of the International Federation of Psychiatric Epidemiology. He has had advisory roles with the United Nations, World Health Organization, the World Bank and UNICEF. He has advised Australia’s Commonwealth Government on developing health profiles for children and young people, mental health policy, suicide prevention, alcohol and illicit substance abuse and men’s health Brenda Penninx Brenda Penninx is Professor of Psychiatric Epidemiology at the VU University Medical Center in Amsterdam, The Netherlands, and leader of mental health programmes in the Neuroscience Campus Amsterdam and the EMGO institute of Health and Care Research. She is principal investigator of the longitudinal, multi-site Netherlands Study of Depression and Anxiety and involved in various EU- or NIH-funded observational and interventional studies for depressive and anxiety disorders. She has published more than 500 papers on the pathophysiology of depressive and anxiety disorders and their course and impact on somatic and public health outcomes. Marta B Rondón Marta B Rondón is a Peruvian psychiatrist working in women’s mental health. She was a member of the Organizing Committee of the International Association of Women’s Mental Health, 1999-2001 and is the current President. She teaches at Cayetano Heredia University in Lima and works for Inppares (a branch of the International Planned Parenthood Federation). She has worked on the supervision of human rights and quality of services for persons with mental illness, the impact of sexual and reproductive rights on the emotional wellbeing of women and the training of primary level health providers to recognize and manage depression in women. She edited Mujer y Salud Mental (1997 – 2000), and sits on the Editorial Board of Revista Peruana de NeuroPsiquiatría and on the Advisory Committee of World Psychiatry (Spanish Edition). Michael R Phillips Michael R Phillips is a Canadian citizen who has been a permanent resident of China for 30 years. He received a BSc (psychology) from McGill University, an MD from McMaster University and an MA (anthropology) and MPH (epidemiology) from the University of Washington. He completed his psychiatry residency training at the University of Washington followed by a two-year Robert Wood Johnson Research Training Fellowship. He is currently Director of the Suicide Research and Prevention Center of the Shanghai Mental Health Center at Shanghai Jiao Tong University School of Medicine, the Executive Director of the WHO Collaborating Center for Research and Training in Suicide Prevention at Beijing Hui Long Guan Hospital, Director of the Shanghai Mental Health Center – Emory University Collaborative Center for Global Mental Health, Professor of Psychiatry and Global Health at Emory University (USA), Professor of Clinical Psychiatry and Clinical Epidemiology at Columbia University (USA), Visiting Professor at Peking Union Medical College, advisor on mental health issues in China for the WHO, China representative to the International Association for Suicide Prevention, Co-Editor-in Chief of the Shanghai Archives of Psychiatry, and editorial consultant for The Lancet. Dr. Phillips is PI on several multi-center collaborative projects on suicide, depression and schizophrenia. He runs a number of research training courses each year, supervises Chinese and foreign graduate students, helps coordinate WHO mental health activities in China, promotes increased awareness of the importance of addressing China’s huge suicide problem and advocates improving the quality, comprehensiveness and access to mental health services around the country. In 2013 he received the International Scientific and Technological Award of the People’s Republic of China, the highest honour for scientific achievement awarded to foreign nationals by the Chinese government. Shekhar Saxena Shekhar Saxena has worked at the World Health Organization since 1998, where he is now Director of the Department of Mental Health and Substance Abuse. As such, he is responsible for implementation of WHO's activities in the area of mental, neurological and substance use disorders, including the mental health Gap Action Programme to scale up care for mental, neurological and substance use disorders in low and middle income countries. His remit includes evaluating evidence on effective public health measures and providing advice and technical assistance to ministries of health on mental, developmental, neurological and substance use disorders issues and establishing partnerships with academic centres and civil society organizations. He supervises the ongoing revision of ICD-10 mental and neurological disorders chapters. Dr Saxena leads WHO’s work to implement the Comprehensive Mental Health Action Plan adopted by the World Health Assembly in May 2013 and the follow up work to the resolution on Autism by the WHO Executive Board in May 2013. Shubalade Smith Shubulade Smith is a Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust and Clinical Senior Lecturer at the Institute of Psychiatry, Psychology and Neuroscience, Kings College London. She graduated from Guy’s Hospital Medical School, winning prizes in Psychological Medicine. Following completion of a research degree, her innovative work around physical health in severe mental illness led to her being nominated as a "Woman of the Year” and receiving a British Medical Association Pioneer award. Shubalade wrote key sections in the influential Schizophrenia Commission, including sections on violence, black mental health, physical health, and treatment. She has research interests in physical health in severe mental illness, management of acute disturbance, and adverse effects of psychotropic medication. Dan J. Stein Dan J. Stein is Professor and Chair of the Dept of Psychiatry and Mental Health at the University of Cape Town, South Africa, Director of the South African Medical Research Council’s Unit on Anxiety & Stress Disorders, and Visiting Professor at Mt Sinai Medical School in New York, USA. His work ranges from basic neuroscience, through clinical research, and on to epidemiological studies. He is enthusiastic about clinical practice and scientific research that integrates concepts and data across these different levels, including in the context of low and middle-income countries. He is a recipient of the Collegium Internationale Neuropsychopharmacologicum’s Max Hamilton Award for his contributions to psychopharmacology, and of its Ethics in Psychopharmacology Award. Charlene Sunkel Charlene Sunkel is a mental health activist who has worked in the mental health field since 2006 and is currently employed as a programme manager for advocacy and development at the South African Federation for Mental Health. She serves on the advisory committee of the Movement for Global Mental Health, is a member of the South African Presidential Working Group on Disability, and serves on several other committees in the field of mental health. She is the author of Empowerment and Partnership in Mental Health – Discovering Their Voice (Lambert Academic Publishing, 2013). Ms Sunkel is a script writer and producer of theatre and film productions that includes her own life story, living with a psychosocial disability. She has received several awards for her work in mental health. Allan Tasman Allan Tasman is Professor and Chairman of Psychiatry and Behavioral Sciences and Schwab Endowed Chair in Social, Community, and Family Psychiatry at the University of Louisville, Kentucky, USA. His research focuses on the neurophysiology of cognitive processes, especially related to depression, alcoholism and autism. He has founded two journals and authored or edited 35 psychiatric textbooks, including being senior editor of all four editions of Psychiatry, a highly regarded comprehensive textbook. He is presently senior editor of the journal Asia Pacific Psychiatry. He is an internationally known educator and leader, having been president of the American Psychiatric Association and four other national and international psychiatric organizations, including the Pacific Rim College of Psychiatrists, and was recently Secretary for Education of the World Psychiatric Association. He has received a number of national and international awards for educational excellence and distinguished professional service. Anita Thapar Anita Thapar is Professor of Child and Adolescent Psychiatry at Cardiff University School of Medicine, UK, and Honorary Consultant in Child and Adolescent Psychiatry, Cwm Taf Health Board. She qualified in medicine at Cardiff and undertook clinical training in child and adolescent psychiatry. She obtained a PhD in genetic epidemiology whilst an MRC Clinical Training Fellow, and became Senior Lecturer in Child and Adolescent Psychiatry at Manchester before moving to Cardiff in 1999. Her research interests are the aetiology of child and adolescent psychiatric disorders, gene-environment interplay and clinical studies of ADHD and depression. She runs clinics for children with complex neurodevelopmental problems. She is lead editor (joint) of the 6th edition of Rutter’s Child & Adolescent Psychiatry. Graham Thornicroft Graham Thornicroft is Professor of Community Psychiatry and works at the Health Service and Population Research Department at the Institute of Psychiatry, King’s College London. He is a Consultant Psychiatrist working in an early intervention community mental health team at the South London and Maudsley NHS Trust. He is also Chair of Maudsley International and the Director of King’s Improvement Science, London, UK. His areas of expertise include: mental health service research, stigma and discrimination, and global mental health. Madhukar H. Trivedi Madhukar H. Trivedi is Professor of Psychiatry, Chief of the Division of Mood Disorders, and Director of the Comprehensive Center for Depression at the University of Texas Southwestern Medical Center. He holds the Betty Jo Hay Distinguished Chair in Mental Health. Dr. Trivedi’s research focuses on the neurobiology of depression as well as pharmacological, psychosocial, and other nonpharmacological treatments for depression. He has been a principal investigator in multiple clinical trials, including the NIDA-funded “Stimulant Reduction Intervention using Dosed Exercise (STRIDE)” study and the Texas Node of the NIDA-funded Clinical Trials Network. He was the Principal Investigator of the Depression Trials Network “Combining Medications to Enhance Depression Outcomes (CO-MED)” trial, which focused on the use of specific antidepressant combinations to increase remission rates by treating a broader spectrum of depressed patients and by capitalizing on additive pharmacological effects. He was also the Co-Principal Investigator of the NIMH-funded, “Sequenced Treatment Alternatives to Relieve Depression (STAR*D).” Most recently, Dr. Trivedi was selected to be the Lead PI for the team conducting the EMBARC project, which is at the core of the NIMH’s initiative to identify a biosignature for depression. Dr. Trivedi has been involved with the National Network of Depression Centers (NNDC) since its inception and led a successful effort through the Research Domain Committee to formulate the Comprehensive Assessment Package being used in these centres. Dr. Trivedi serves as the Co-Chair of the newly formed Biomarker Task Group of the Network. Dr. Trivedi has received numerous awards including the Gerald L. Klerman award from the National Depressive and Manic-Depressive Association Scientific Advisory Board and the Psychiatric Excellence Award from the Texas Society of Psychiatric Physicians. Dr. Trivedi has mentored multiple psychopharmacology postdoctoral fellows and research track residents over the past many years in Mood and Anxiety Disorders and is the Principal Investigator of an NIMH-funded Postdoctoral T32 training program. Eduard Vieta Eduard Vieta is Professor of Psychiatry at the University of Barcelona and Chair of the Department of Psychiatry and Psychology at the Hospital Clinic, where he also leads the Bipolar Disorders Program in Barcelona, Catalonia, Spain. The Bipolar Unit is one of the worldwide leaders in clinical care, teaching and research on bipolar disorder. Dr. Vieta is the current Director of the Bipolar Research Program at the Spanish Research Network on Mental Health (CIBERSAM). He has received several awards, including the Aristotle award (2005), the Mogens Schou award (2007), the Strategic Research award of the Spanish Society of Biological Psychiatry (2009), the Official College of Physicians award to Professional Excellence (2011) and the Colvin Price on Outstanding Achievement in Mood Disorders Research by the Brain and Behaviour Research Foundation (2012). Jan Wallcraft Dr Jan Wallcraft is a freelance researcher whose work is informed by personal experience of mental health services in her 20s. She has worked in service user involvement for a range of NGOs and published articles on aspects of person-centred medicine and partnership working with service users and families. Her PhD from South Bank University London looked at the impact of first experiences of psychiatric hospitalisation. She is a Research Associate at Wolverhampton University, and a Fellow of Birmingham and Hertfordshire Universities. She was lead editor on the Handbook of Service User Involvement in Mental Health Research (John Wiley & Sons, 2009). Charlotte Walker Charlotte Walker has worked in health and social care for 15 years, in maternity services, clinical effectiveness and criminal justice. She is currently drawing upon her lived experience of bipolar disorder to develop a portfolio career in mental health which in turn supports her recovery. Charlotte is an Expert by Experience for the mental health charity Mind and is involved in training, consultancy, writing and research in the field. Charlotte won the Mark Hanson Award for Digital Media at the Mind Media Awards 2013 for her blog, purplepersuasion, and maintains a large online network of service users, carers, professionals, commissioners and policy makers. Danuta Wasserman Danuta Wasserman is Professor in Psychiatry and Suicidology at the Karolinska Institutet in Stockolm, Sweden, and the Founding Head of the National Centre for Suicide Research and Prevention of Mental Ill-Health there. She has been the Director of the WHO Collaborating Centre for Research, Methods Development and Training in Suicide Prevention since 1995. She is President of the European Psychiatric Association and former President of the International Academy of Suicide Research. Professor Wasserman is the editor of the Oxford Textbook of Suicidology and Suicide Prevention: A Global Perspective and has received several National and International honours and awards. In 2012, she received the British Medical Association Medical Book Award for her book Depression: The Facts, Second Edition (Oxford University Press). Professor Wasserman's research includes epidemiological, psychodynamic and genetic studies of suicidal behaviours. She is the Principal Investigator of two large-scale randomized controlled trials funded for €3 million each by the European Union. Yu Xin Yu Xin is Professor of Clinical Psychiatry at Peking University Institute of Mental Health, China. He led the institute as the director from 2001-2013. He was the Founding President of the Chinese Psychiatrist Association and is currently the President of the Chinese Society of Psychiatry. His major research interests are geriatric psychiatry, early psychosis intervention and bipolar disorders. He is the chief consultant for the Chinese National Health and Family Planning Commission in terms of mental health policy and mental health service delivery. He is also the clinical director of the community-based psychosis management programme in China. Carlos Zarate Carlos Zarate is Chief Experimental Therapeutics & Pathophysiology Branch and of the Section on Neurobiology and Treatment of Mood and Anxiety Disorders, Division Intramural Research Program, National Institute of Mental Health, USA. He received the National Alliance for Research on Schizophrenia and Depression Independent Investigator award; the National Institutes of Health Director’s award Scientific/Medical 2011, 2013; the 2011 Brain & Behavior Research Foundation award for Bipolar Mood Disorder Research, and the Mogens Schou Bipolar Disorder Research award. Dr. Zarate is a member of the American College of Neuropsychopharmacology, Biological Psychiatry and the Society for Neuroscience. Stephan Zipfel Stephan Zipfel is Professor of Psychosomatic Medicine and Psychotherapy at the University of Tübingen and head of the Department of Psychosomatic Medicine at the University Medical Hospital Tübingen, Germany. He is the Acting President of the German College of Psychosomatic Medicine (DKPM) and a Board member of the International Federation of Psychotherapy. He is Director of the Centre for Nutritional Science at the Universities of Tübingen & Hohenheim, Germany and Dean of Medical Education at the Medical Faculty of the University of Tübingen. He has published widely on eating and somatoform disorders, placebo research and medical education